Preclinical evaluation of L-fucoside from lapachol-loaded nanoemulsion as a strategy to breast cancer treatment

Preclinical evaluation of L-fucoside from lapachol-loaded nanoemulsion as a strategy to breast cancer treatment

Breast cancer prevails as the most common cancer in women, underscoring an urgent need for more effective therapies. This study explores the potential of our newly developed nanoemulsion containing a novel fucoside derivative of lapachol (NE-F-LapA) as an intravenous treatment strategy. We sought to...

Full description

Bibliographic Details
Main Authors: Sued Eustaquio Mendes Miranda, Janaina de Alcantara Lemos, Flaviano Melo Ottoni, Geovanni Dantas Cassali, Danyelle M. Townsend, Carolina de Aguiar Ferreira, Ricardo Jose Alves, Lucas Antonio Miranda Ferreira, Andre Luis Branco de Barros
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Lapachol
Tumor
Nanoemulsion
Drug delivery
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223018528

Internet

http://www.sciencedirect.com/science/article/pii/S0753332223018528

Similar Items